BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27836482)

  • 1. Pathway to pharmacist medical provider status in Washington State.
    Hazlet TK; Karwaki TE; Downing DF
    J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reimbursement for pharmacist-provided health care services: A multistate review.
    Nguyen E; Walker K; Adams JL; Wadsworth T; Robinson R
    J Am Pharm Assoc (2003); 2021; 61(1):27-32. PubMed ID: 33069593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 7. National billing codes announced for pharmacists' clinical services.
    Thompson CA
    Am J Health Syst Pharm; 2005 Aug; 62(16):1640-2. PubMed ID: 16085922
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacist 'provider status' legislation introduced into the Senate.
    Young D
    Am J Health Syst Pharm; 2003 Aug; 60(15):1502. PubMed ID: 12951746
    [No Abstract]   [Full Text] [Related]  

  • 9. What Does Provider Status Mean for Pharmacists?
    Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
    [No Abstract]   [Full Text] [Related]  

  • 10. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
    Scott MA; Hitch WJ; Wilson CG; Lugo AM
    J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Getting Paid for Clinical Services.
    Martin CM
    Consult Pharm; 2018 May; 33(5):240-246. PubMed ID: 29789045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remunerated patient care services and injections by pharmacists: An international update.
    Houle SKD; Carter CA; Tsuyuki RT; Grindrod KA
    J Am Pharm Assoc (2003); 2019; 59(1):89-107. PubMed ID: 30195440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist services: insurance need not be the only answer.
    Winckler SC
    J Am Pharm Assoc (Wash); 2002; 42(6):826. PubMed ID: 12482003
    [No Abstract]   [Full Text] [Related]  

  • 15. Billing third party payers for pharmaceutical care services.
    Poirier S; Buffington DE; Memoli GA
    J Am Pharm Assoc (Wash); 1999; 39(1):50-64; quiz 101-2. PubMed ID: 9990188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analysis and Comparison of Medication Therapy Management Cost-Avoidance vs. Fee-for-Service Financial Models.
    Schuh MJ
    Consult Pharm; 2015 May; 30(5):291-7. PubMed ID: 25979129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.
    George JC; Popma JJ
    JACC Cardiovasc Interv; 2009 Sep; 2(9):894-6. PubMed ID: 19778781
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicaid and indigent care issue brief: Medicaid: provider reimbursement.
    Johnson P
    Issue Brief Health Policy Track Serv; 2000 Jul; ():1-15. PubMed ID: 11073441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.